0001709542 2024-01-01 2024-09-30 0001709542 2026-06-01 0001709542 2024-09-30 0001709542 2023-12-31 0001709542 us-gaap:SeriesAPreferredStockMember 2024-09-30 0001709542 us-gaap:SeriesAPreferredStockMember 2023-12-31 0001709542 2024-07-01 2024-09-30 0001709542 2023-07-01 2023-09-30 0001709542 2023-01-01 2023-09-30 0001709542 us-gaap:PreferredStockMember 2023-12-31 0001709542 us-gaap:CommonStockMember 2023-12-31 0001709542 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001709542 us-gaap:RetainedEarningsMember 2023-12-31 0001709542 us-gaap:PreferredStockMember 2024-03-31 0001709542 us-gaap:CommonStockMember 2024-03-31 0001709542 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001709542 us-gaap:RetainedEarningsMember 2024-03-31 0001709542 2024-03-31 0001709542 us-gaap:PreferredStockMember 2024-06-30 0001709542 us-gaap:CommonStockMember 2024-06-30 0001709542 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001709542 us-gaap:RetainedEarningsMember 2024-06-30 0001709542 2024-06-30 0001709542 us-gaap:PreferredStockMember 2022-12-31 0001709542 us-gaap:CommonStockMember 2022-12-31 0001709542 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001709542 us-gaap:RetainedEarningsMember 2022-12-31 0001709542 2022-12-31 0001709542 us-gaap:PreferredStockMember 2023-03-31 0001709542 us-gaap:CommonStockMember 2023-03-31 0001709542 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001709542 us-gaap:RetainedEarningsMember 2023-03-31 0001709542 2023-03-31 0001709542 us-gaap:PreferredStockMember 2023-06-30 0001709542 us-gaap:CommonStockMember 2023-06-30 0001709542 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001709542 us-gaap:RetainedEarningsMember 2023-06-30 0001709542 2023-06-30 0001709542 us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001709542 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001709542 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001709542 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001709542 2024-01-01 2024-03-31 0001709542 us-gaap:PreferredStockMember 2024-04-01 2024-06-30 0001709542 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001709542 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001709542 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001709542 2024-04-01 2024-06-30 0001709542 us-gaap:PreferredStockMember 2024-07-01 2024-09-30 0001709542 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001709542 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001709542 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001709542 us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001709542 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001709542 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001709542 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001709542 2023-01-01 2023-03-31 0001709542 us-gaap:PreferredStockMember 2023-04-01 2023-06-30 0001709542 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001709542 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001709542 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001709542 2023-04-01 2023-06-30 0001709542 us-gaap:PreferredStockMember 2023-07-01 2023-09-30 0001709542 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001709542 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001709542 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001709542 us-gaap:PreferredStockMember 2024-09-30 0001709542 us-gaap:CommonStockMember 2024-09-30 0001709542 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001709542 us-gaap:RetainedEarningsMember 2024-09-30 0001709542 us-gaap:PreferredStockMember 2023-09-30 0001709542 us-gaap:CommonStockMember 2023-09-30 0001709542 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001709542 us-gaap:RetainedEarningsMember 2023-09-30 0001709542 2023-09-30 0001709542 xesp:PhitechManagementLLCMember 2023-12-21 2023-12-22 0001709542 srt:ChiefExecutiveOfficerMember 2023-12-21 2023-12-22 0001709542 xesp:WarrantsMember 2024-01-01 2024-09-30 0001709542 us-gaap:OptionMember 2024-01-01 2024-09-30 0001709542 xesp:WarrantsMember 2023-01-01 2023-09-30 0001709542 us-gaap:OptionMember 2023-01-01 2023-09-30 0001709542 xesp:ThirdParty1Member 2022-05-19 0001709542 xesp:ThirdParty1Member 2022-05-18 2022-05-19 0001709542 xesp:ThirdParty1Member 2024-09-30 0001709542 xesp:ThirdParty1Member 2023-12-31 0001709542 xesp:ThirdParty2Member 2022-05-20 0001709542 xesp:ThirdParty2Member 2022-05-16 2022-05-20 0001709542 xesp:ThirdParty2Member 2024-09-30 0001709542 xesp:ThirdParty2Member 2023-12-31 0001709542 xesp:ThirdParty3Member 2022-06-10 0001709542 xesp:ThirdParty3Member 2022-06-01 2022-06-10 0001709542 xesp:ThirdParty3Member 2024-09-30 0001709542 xesp:ThirdParty3Member 2023-12-31 0001709542 xesp:ThirdParty4Member 2022-10-18 0001709542 xesp:ThirdParty4Member 2022-10-17 2022-10-18 0001709542 xesp:ThirdParty4Member 2024-09-30 0001709542 xesp:ThirdParty4Member 2023-12-31 0001709542 xesp:ThirdParty5Member 2023-01-06 0001709542 xesp:ThirdParty5Member 2023-01-01 2023-01-06 0001709542 xesp:ThirdParty5Member 2024-09-30 0001709542 xesp:ThirdParty5Member 2023-12-31 0001709542 xesp:ThirdParty6Member 2023-03-13 0001709542 xesp:ThirdParty6Member 2023-03-01 2023-03-13 0001709542 xesp:ThirdParty6Member 2024-09-30 0001709542 xesp:ThirdParty6Member 2023-12-31 0001709542 xesp:ThirdParty7Member 2023-05-11 0001709542 xesp:ThirdParty7Member 2023-05-01 2023-05-11 0001709542 xesp:ThirdParty7Member 2024-09-30 0001709542 xesp:ThirdParty7Member 2023-12-31 0001709542 xesp:ThirdParty8Member 2023-05-15 0001709542 xesp:ThirdParty8Member 2023-05-01 2023-05-15 0001709542 xesp:ThirdParty8Member 2024-09-30 0001709542 xesp:ThirdParty8Member 2023-12-31 0001709542 xesp:ThirdParty9Member 2023-09-01 0001709542 xesp:ThirdParty9Member 2023-08-30 2023-09-01 0001709542 xesp:ThirdParty9Member 2024-09-30 0001709542 xesp:ThirdParty9Member 2023-12-31 0001709542 xesp:ThirdParty10Member 2023-09-06 0001709542 xesp:ThirdParty10Member 2023-09-05 2023-09-06 0001709542 xesp:ThirdParty10Member 2024-09-30 0001709542 xesp:ThirdParty10Member 2023-12-31 0001709542 xesp:ThirdParty11Member 2023-09-15 0001709542 xesp:ThirdParty11Member 2023-09-14 2023-09-15 0001709542 xesp:ThirdParty11Member 2024-09-30 0001709542 xesp:ThirdParty11Member 2023-12-31 0001709542 xesp:Forty7SelectHoldingsLLCMember 2024-09-30 0001709542 xesp:Forty7SelectHoldingsLLCMember 2023-12-31 0001709542 xesp:Forty7SelectHoldingsLLCMember 2023-01-10 0001709542 xesp:Forty7SelectHoldingsLLCMember 2023-01-01 2023-01-10 0001709542 xesp:AssetPurchaseAgreementMember 2023-12-22 0001709542 xesp:GregShockeyMember 2022-04-11 2022-04-12 0001709542 xesp:GregShockeyMember 2023-02-01 0001709542 us-gaap:EmployeeStockOptionMember xesp:ShockeyGrantAndAgreementMember 2023-10-11 2023-10-12 0001709542 xesp:DanijellaDragasMember 2022-04-11 2022-04-12 0001709542 xesp:ThomasSpruceMember 2022-01-01 2022-03-31 0001709542 xesp:ThomasSpruceMember 2022-05-26 2022-05-27 0001709542 xesp:ThomasSpruceMember xesp:ChiefOperationsOfficerMember 2023-01-30 2023-02-01 0001709542 xesp:ThomasSpruceMember xesp:ChiefOperationsOfficerMember 2023-02-01 0001709542 xesp:ThomasSpruceMember xesp:ChiefOperationsOfficerMember 2023-03-29 2023-04-02 0001709542 us-gaap:EmployeeStockOptionMember xesp:SpruceEmploymentAgreementAndGrantMember 2023-10-11 2023-10-12 0001709542 xesp:JimKelloggMember 2022-11-15 2022-11-16 0001709542 us-gaap:EmployeeStockOptionMember xesp:KelloggEmploymentAgreementAndGrantMember 2023-10-11 2023-10-12 0001709542 srt:ChiefExecutiveOfficerMember 2023-01-31 2023-02-01 0001709542 srt:ChiefExecutiveOfficerMember 2023-02-01 0001709542 srt:ChiefExecutiveOfficerMember 2023-01-30 2023-02-01 0001709542 us-gaap:EmployeeStockOptionMember xesp:HagerGrantAndAgreementMember 2023-10-11 2023-10-12 0001709542 xesp:JonathanSweetserMember 2023-09-27 2023-09-28 0001709542 xesp:HeatherRawlsMember 2023-09-27 2023-09-28 0001709542 xesp:OptionsIssuedFeb2023Member 2024-01-01 2024-09-30 0001709542 xesp:OptionsIssuedSept2023Member 2024-01-01 2024-09-30 0001709542 xesp:OptionsIssuedNov2022Member 2024-01-01 2024-09-30 0001709542 xesp:OptionsIssuedFeb2023Member 2023-02-01 0001709542 xesp:OptionsIssuedFeb2023Member 2023-01-30 2023-02-01 0001709542 xesp:OptionsIssuedSept2023Member 2023-09-28 0001709542 xesp:OptionsIssuedSept2023Member 2023-09-27 2023-09-28 0001709542 xesp:OptionsIssuedNov2022Member 2023-09-30 0001709542 xesp:OptionsIssuedNov2022Member 2023-07-01 2023-09-30 0001709542 us-gaap:StockOptionMember 2022-12-31 0001709542 us-gaap:StockOptionMember 2022-01-01 2022-12-31 0001709542 us-gaap:StockOptionMember 2023-01-01 2023-12-31 0001709542 us-gaap:StockOptionMember 2023-12-31 0001709542 us-gaap:StockOptionMember 2024-01-01 2024-09-30 0001709542 us-gaap:StockOptionMember 2024-09-30 0001709542 xesp:StockWarrantsMember 2022-12-31 0001709542 xesp:StockWarrantsMember 2023-01-01 2023-12-31 0001709542 xesp:StockWarrantsMember 2023-12-31 0001709542 xesp:StockWarrantsMember 2024-01-01 2024-09-30 0001709542 xesp:StockWarrantsMember 2024-09-30 iso4217:USD shares iso4217:USD shares pure xesp:Integer false --12-31 2024 Q3 0001709542

10-Q true 2024-09-30 false 000-55809 ELECTRONIC SERVITOR PUBLICATION NETWORK INC. DE 82-1873116 107 CHESTNUT ST. STE. 100 STILLWATER MN 55082-5542 833 991-0800 No No Non-accelerated Filer true false false 53528001

28431

2500

28431

85001

66140

229630

2500000

26700 34450

2841331

2830220

0.0001

19999000

0.0001

1000

0.0001

100000000

52328001

51428001

5233

5143

4870202

4387751

-7714266

-7194683

-2838831

-2801789

2500

28431

22500

50000

45000

21847

312045

79989

354999

14500

51300

64021

139847

99054

419541

390604

161694

425599

550830

809624

-161694

-403099

-500830

-764624

6251

4739

18753

11399

-6251

-4739

-18753

-11399

-167945

-407838

-519583

-776023

-0

-167945

-407838

-519583

-776023

-0.00

-0.02

-0.01

-0.03

52328001

21463223

52028001

21458714

1000

51428001

5143

4387751

-7194683

-2801789

139847

300000

20970

21000

-173068

1000

51728001

5173

4548568

-7367751

-2814010

139847

300000

20970

21000

-178570

1000

52028001

5203

4709385

-7546321

-2831733

139847

300000

20970

21000

-167945

1000

52328001

5233

4870202

-7714266

-2838831

1000

21416001

2142

6224900

-6362481

-135439

219155

-267329

1000

21416001

2142

6444055

-6629810

-183613

72395

-100856

1000

21416001

2142

6516450

-6730666

-212074

4060000

406

283794

284200

99054

-407838

1000

25476001

2548

6899298

-7138504

-236658

-519583

-776023

419541

674804

63000 0

2500

-0

18861

10565

-20681

-90654

17200

177000

7750

43018

-7750

151182

-28431

60528

28431

17139

77667

NOTE 1 – DESCRIPTION OF BUSINESS AND HISTORY Description of business The Company was originally incorporated on May 17, 2017, under the laws of the State of Delaware to engage in any lawful corporate undertaking, including, but not limited to, selected mergers and acquisitions. The Company’s common stock trades on the OTC Expert Market under the stock ticker symbol “XESP.” The Company’s corporate office is located at 107 Chestnut St., Suite 100, Stillwater, MN 55082-5542. The URL of the Company’s website is https://www.electronicservitor.com. The Company is a digital engagement company providing growth for B2B companies through its digital activation and engagement solutions for multiple verticals. The Company’s managed service product is powered by a sophisticated tech stack — the Digital Engagement Engine. The Company’s technology provides intelligent interaction management, dynamic content provisioning, and a logic-driven workflow that creates relevant digital experiences that accelerate an audience from awareness to action — driving growth for client companies. On December 22, 2023, the Company entered into the following transactions: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">1)</td> <td style="text-align: justify">An Asset Purchase Agreement (the “Asset Purchase Agreement”) with Phitech Management, LLC, a limited liability company organized under the laws of Minnesota (“Phitech”); and</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td>2)</td> <td style="text-align: justify">An Agreement and Plan of Merger (the “Merger Agreement”) with Pointward Inc., a corporation organized under the laws of Delaware (“Pointward”).</td></tr> </table> Pursuant to the terms of the Asset Purchase Agreement, the Company has agreed to pay an aggregate purchase price of $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pp0p0_c20231221__20231222__us-gaap--TypeOfArrangementAxis__custom--PhitechManagementLLCMember_zCPplapLt1Xb" title="Number of shares issued, value">2,500,000, plus the assumption of the assumed liabilities as defined in such Asset Purchase Agreement, for Phitech’s assets, including its proprietary technology; and, upon consummation of the transaction, the Company shall cancel <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20231221__20231222__us-gaap--TypeOfArrangementAxis__custom--PhitechManagementLLCMember_z5B3eCZm868" title="Number of shares issued">10,000,000 shares of the Company’s common stock held by Phitech, representing 100% of Phitech’s ownership of the Company, and such shares shall be returned to the Company’s treasury. Pursuant to the terms of the Merger Agreement, the Company shall be the surviving corporation and all the outstanding capital stock of Pointward was converted into shares of the Company’s common stock. Accordingly, the Company issued 39,252,000 shares of the Company’s common stock to the former holders of Pointward and the former stockholders of Pointward (not including any ownership of the Company’s capital stock held by such persons prior to the Merger) hold approximately 72% of the outstanding shares of the Company’s capital stock. As a result of the transactions described above, the Company is strategically aligning its business to support its mission in becoming the premier content management and distribution platform for content providers in the global markets through the Company’s continued development and acquisitions of publication and monetization products, services, and technologies.

2500000

10000000

39252000

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The Company’s unaudited financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”), and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) and reflect all adjustments, consisting of normal recurring adjustments, which management believes are necessary to fairly present the financial position, results of operations and cash flows of the Company as of and for the period ended September 30, 2024 and not necessarily indicative of the results to be expected for the full year ending December 31, 2024. These unaudited financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Concentrations of Credit Risk The Company maintains its cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. The Company continually monitors its banking relationships and consequently has not experienced any losses in its accounts. At times, such deposits may be in excess of the Federal Deposit Insurance Corporation insurable amount (“FDIC”). Cash Equivalents The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents as of September 30, 2024 and December 31, 2023. Basic and Diluted Earnings Per Share Under ASC 260 “Earnings Per Share,” the Company presents basic and diluted earnings (loss) per share (“EPS”) amounts on the face of the statements of operations. Basic EPS is computed by dividing income (loss) available to common stockholders (the numerator) by the weighted-average number of common shares outstanding (the denominator) during the period. Shares issued during the period and shares reacquired during the period are weighted for the portion of the period that they were outstanding. The computation of diluted EPS is similar to the computation of basic EPS except that the denominator is increased to include the number of additional common shares that would have been outstanding if the dilutive potential common shares had been issued. As of September 30, 2024, there are <span id="xdx_909_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20240930__us-gaap--AwardTypeAxis__custom--WarrantsMember_zXDLwxoPLto8" title="Number of diluted shares">153,503 potentially dilutive shares from warrants and <span id="xdx_908_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20240930__us-gaap--FinancialInstrumentAxis__us-gaap--OptionMember_zkgk2yRaPs6i" title="Number of diluted shares">10,805,000 potentially dilutive shares from vested options. As of September 30, 2023, there are <span id="xdx_90B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20230930__us-gaap--AwardTypeAxis__custom--WarrantsMember_zenBs96YsxQ8" title="Number of diluted shares">153,503 potentially dilutive shares from warrants and <span id="xdx_902_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20230930__us-gaap--FinancialInstrumentAxis__us-gaap--OptionMember_zA0JAdFZrfk9" title="Number of diluted shares">4,580,000 potentially dilutive shares from vested options. Additionally, diluted amounts are not presented when the effect of the computations is anti-dilutive due to the losses incurred. Accordingly, there is no difference in the amounts presented for basic and diluted loss per share. Revenue Recognition The Company recognizes revenue under ASC 606, “Revenue from Contracts with Customers” (“ASC 606”). The Company determines revenue recognition through the following steps: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 2%; text-align: justify"> </td> <td style="width: 3%; text-align: justify">·</td> <td style="width: 95%; text-align: justify">Identification of a contract with a customer;</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify">·</td> <td style="text-align: justify">Identification of the performance obligations in the contract;</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify">·</td> <td style="text-align: justify">Determination of the transaction price;</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify">·</td> <td style="text-align: justify">Allocation of the transaction price to the performance obligations in the contract; and</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify">·</td> <td style="text-align: justify">Recognition of revenue when or as the performance obligations are satisfied.</td></tr> </table> Revenue is recognized when control of the promised goods or services is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. As a practical expedient, the Company does not adjust the transaction price for the effects of a significant financing component if, at contract inception, the period between customer payment and the transfer of goods or services is expected to be one year or less. Stock-based Compensation In June 2018, the FASB issued ASU 2018-07, Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. ASU 2018-07 allows companies to account for nonemployee awards in the same manner as employee awards. The guidance is effective for fiscal years beginning after December 15, 2018, and interim periods within those annual periods. We adopted this ASU on January 1, 2019. Fair value of financial instruments The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments and paragraph 820-10-35-37 of the FASB Accounting Standards Codification (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in accounting principles generally accepted in the United States of America under U.S. GAAP and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 8%; text-align: justify">Level 1:</td> <td style="width: 92%; text-align: justify">Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">Level 2:</td> <td style="text-align: justify">Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">Level 3:</td> <td style="text-align: justify">Pricing inputs that are generally unobservable inputs and not corroborated by market data.</td></tr> </table> The carrying amount of the Company’s financial assets and liabilities, such as cash, accounts payable, accrued expenses and loans payable approximate their fair value because of the short maturity of those instruments. The Company had no financial instruments at September 30, 2024 and December 31, 2023 that required fair value hierarchy disclosure. Income Taxes Income taxes are provided for the tax effects of the transactions reported in the financial statements and consist of taxes currently due plus deferred taxes related primarily to tax net operating loss carryforwards. The deferred tax assets and liabilities represent the future tax return consequences of these differences, which will either be taxable or deductible when assets and liabilities are recovered or settled, as well as operating loss carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is established against deferred tax assets when in the judgment of management, it is more likely than not that such deferred tax assets will not become available. Because the judgment about the level of future taxable income is dependent to a great extent on matters that may, at least in part, be beyond the Company’s control, it is at least reasonably possible that management’s judgment about the need for a valuation allowance for deferred taxes could change in the near term. Tax benefits are recognized only for tax positions that are more likely than not to be sustained upon examination by tax authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50 percent likely to be realized upon settlement. A liability for “unrecognized tax benefits” is recorded for any tax benefits claimed in the Company’s tax returns that do not meet these recognition and measurement standards. As of September 30, 2024 and December 31, 2023, no liability for unrecognized tax benefits was required to be reported. Operating Segments Operating segments are defined as components of an entity for which discrete financial information is available that is regularly reviewed by the Chief Operating Decision Maker (“CODM”), or decision maker group, in deciding how to allocate resources to an individual segment and in assessing performance. Our CODM is composed of the Chief Executive Officer. The Company has one operating segment generating revenue as of September 30, 2024. Recently issued accounting pronouncements The Company periodically reviews new accounting standards that are issued. Although some of these accounting standards may apply to the Company, the Company has not identified any new standards that it believes merit further discussion or change to adopted policies, and the Company expects that none will have a significant impact on its financial statements.

Basis of Presentation The Company’s unaudited financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”), and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) and reflect all adjustments, consisting of normal recurring adjustments, which management believes are necessary to fairly present the financial position, results of operations and cash flows of the Company as of and for the period ended September 30, 2024 and not necessarily indicative of the results to be expected for the full year ending December 31, 2024. These unaudited financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023.

Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Concentrations of Credit Risk The Company maintains its cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. The Company continually monitors its banking relationships and consequently has not experienced any losses in its accounts. At times, such deposits may be in excess of the Federal Deposit Insurance Corporation insurable amount (“FDIC”).

Cash Equivalents The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents as of September 30, 2024 and December 31, 2023.

Basic and Diluted Earnings Per Share Under ASC 260 “Earnings Per Share,” the Company presents basic and diluted earnings (loss) per share (“EPS”) amounts on the face of the statements of operations. Basic EPS is computed by dividing income (loss) available to common stockholders (the numerator) by the weighted-average number of common shares outstanding (the denominator) during the period. Shares issued during the period and shares reacquired during the period are weighted for the portion of the period that they were outstanding. The computation of diluted EPS is similar to the computation of basic EPS except that the denominator is increased to include the number of additional common shares that would have been outstanding if the dilutive potential common shares had been issued. As of September 30, 2024, there are <span id="xdx_909_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20240930__us-gaap--AwardTypeAxis__custom--WarrantsMember_zXDLwxoPLto8" title="Number of diluted shares">153,503 potentially dilutive shares from warrants and <span id="xdx_908_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20240930__us-gaap--FinancialInstrumentAxis__us-gaap--OptionMember_zkgk2yRaPs6i" title="Number of diluted shares">10,805,000 potentially dilutive shares from vested options. As of September 30, 2023, there are <span id="xdx_90B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20230930__us-gaap--AwardTypeAxis__custom--WarrantsMember_zenBs96YsxQ8" title="Number of diluted shares">153,503 potentially dilutive shares from warrants and <span id="xdx_902_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20230930__us-gaap--FinancialInstrumentAxis__us-gaap--OptionMember_zA0JAdFZrfk9" title="Number of diluted shares">4,580,000 potentially dilutive shares from vested options. Additionally, diluted amounts are not presented when the effect of the computations is anti-dilutive due to the losses incurred. Accordingly, there is no difference in the amounts presented for basic and diluted loss per share.

153503

10805000

153503

4580000

Revenue Recognition The Company recognizes revenue under ASC 606, “Revenue from Contracts with Customers” (“ASC 606”). The Company determines revenue recognition through the following steps: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 2%; text-align: justify"> </td> <td style="width: 3%; text-align: justify">·</td> <td style="width: 95%; text-align: justify">Identification of a contract with a customer;</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify">·</td> <td style="text-align: justify">Identification of the performance obligations in the contract;</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify">·</td> <td style="text-align: justify">Determination of the transaction price;</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify">·</td> <td style="text-align: justify">Allocation of the transaction price to the performance obligations in the contract; and</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify">·</td> <td style="text-align: justify">Recognition of revenue when or as the performance obligations are satisfied.</td></tr> </table> Revenue is recognized when control of the promised goods or services is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. As a practical expedient, the Company does not adjust the transaction price for the effects of a significant financing component if, at contract inception, the period between customer payment and the transfer of goods or services is expected to be one year or less.

Stock-based Compensation In June 2018, the FASB issued ASU 2018-07, Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. ASU 2018-07 allows companies to account for nonemployee awards in the same manner as employee awards. The guidance is effective for fiscal years beginning after December 15, 2018, and interim periods within those annual periods. We adopted this ASU on January 1, 2019.

Fair value of financial instruments The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments and paragraph 820-10-35-37 of the FASB Accounting Standards Codification (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in accounting principles generally accepted in the United States of America under U.S. GAAP and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 8%; text-align: justify">Level 1:</td> <td style="width: 92%; text-align: justify">Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">Level 2:</td> <td style="text-align: justify">Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">Level 3:</td> <td style="text-align: justify">Pricing inputs that are generally unobservable inputs and not corroborated by market data.</td></tr> </table> The carrying amount of the Company’s financial assets and liabilities, such as cash, accounts payable, accrued expenses and loans payable approximate their fair value because of the short maturity of those instruments. The Company had no financial instruments at September 30, 2024 and December 31, 2023 that required fair value hierarchy disclosure.

Income Taxes Income taxes are provided for the tax effects of the transactions reported in the financial statements and consist of taxes currently due plus deferred taxes related primarily to tax net operating loss carryforwards. The deferred tax assets and liabilities represent the future tax return consequences of these differences, which will either be taxable or deductible when assets and liabilities are recovered or settled, as well as operating loss carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is established against deferred tax assets when in the judgment of management, it is more likely than not that such deferred tax assets will not become available. Because the judgment about the level of future taxable income is dependent to a great extent on matters that may, at least in part, be beyond the Company’s control, it is at least reasonably possible that management’s judgment about the need for a valuation allowance for deferred taxes could change in the near term. Tax benefits are recognized only for tax positions that are more likely than not to be sustained upon examination by tax authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50 percent likely to be realized upon settlement. A liability for “unrecognized tax benefits” is recorded for any tax benefits claimed in the Company’s tax returns that do not meet these recognition and measurement standards. As of September 30, 2024 and December 31, 2023, no liability for unrecognized tax benefits was required to be reported.

Operating Segments Operating segments are defined as components of an entity for which discrete financial information is available that is regularly reviewed by the Chief Operating Decision Maker (“CODM”), or decision maker group, in deciding how to allocate resources to an individual segment and in assessing performance. Our CODM is composed of the Chief Executive Officer. The Company has one operating segment generating revenue as of September 30, 2024.

Recently issued accounting pronouncements The Company periodically reviews new accounting standards that are issued. Although some of these accounting standards may apply to the Company, the Company has not identified any new standards that it believes merit further discussion or change to adopted policies, and the Company expects that none will have a significant impact on its financial statements.

NOTE 3 – GOING CONCERN The accompanying unaudited condensed financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has begun to recognize limited revenue and has an accumulated deficit of $7,714,266 as of September 30, 2024. The Company’s continuation as a going concern is dependent upon its ability to generate revenue to satisfy its obligations on a timely basis and ultimately to attain profitability. There is no guarantee that the Company’s activities will generate sufficient revenues to sustain its operations. To maintain operations, the Company may have to raise additional capital from equity financing and/or from its officers, directors, or principal stockholders, subject to terms obtainable and satisfactory to the Company. There is no guarantee that the Company will be able to raise additional funds or to do so at an advantageous price. The unaudited condensed financial statements of the Company do not include any adjustments that may result from the outcome of these uncertainties.

-7714266

NOTE 4 – NOTES PAYABLE On May 19, 2022, the Company issued a note payable for $10,000 to a third party. The note matured one year from the date of issuance and bears interest at 6% per annum. As of September 30, 2024 and December 31, 2023, there is $1,425 and $972 of interest accrued on this note, respectively. This note is currently in default. On May 20, 2022, the Company issued a note payable for $10,000 to a third party. The note matured one year from the date of issuance and bears interest at 6% per annum. As of September 30, 2024 and December 31, 2023, there is $1,424 and $970 of interest accrued on this note, respectively. This note is currently in default. On June 10, 2022, the Company issued a note payable to a third party for $7,630. The note matured 6 months from the date of issuance and bears interest at 10% per annum. As of September 30, 2024 and December 31, 2023, there is $1,766 and $1,189 of interest accrued on this note, respectively. This note is currently in default. On October 18, 2022, the Company issued a note payable for $25,000 to a third party. The note matured one year from the date of issuance and bears interest at 8% per annum. As of September 30, 2024 and December 31, 2023, there is $3,918 and $2,405 of interest accrued on this note, respectively. This note is currently in default. On January 6, 2023, the Company issued a note payable for $15,000 to a third party. The note matured on July 6, 2023, and bears interest at 8.5% per annum. As of September 30, 2024 and December 31, 2023, there is $2,218 and $1,254 of interest accrued on this note, respectively. This note is currently in default. On March 13, 2023, the Company issued a note payable for $12,000 to a third party. The note matured on September 13, 2023, and bears interest at 8.5% per annum. As of September 30, 2024 and December 31, 2023, there is $1,590 and $819 of interest accrued on this note, respectively. This note is currently in default. On May 11, 2023, the Company issued a note payable to a third party for $25,000. The note matured on May 11, 2024, and bears interest at 8% per annum. As of September 30, 2024 and December 31, 2023, there is $2,795 and $1,282 of interest accrued on this note, respectively. On May 15, 2023, the Company issued a note payable for $25,000 to a third party. The note matured on May 15, 2024, and bears interest at 8% per annum. As of September 30, 2024 and December 31, 2023, there is $2,773 and $1,260 of interest accrued on this note, respectively. On September 1, 2023, the Company issued a note payable to a third party for $25,000. The note matured on September 1, 2024, and bears interest at 8% per annum. As of September 30, 2024 and December 31, 2023, there is $2,175 and $663 of interest accrued on this note, respectively. On September 6, 2023, the Company issued a note payable for $50,000 to a third party. The note matured on September 6, 2024, and bears interest at 8% per annum. As of September 30, 2024 and December 31, 2023, there is $4,296 and $1,271 of interest accrued on this note, respectively. On September 15, 2023, the Company issued a note payable for $50,000 to a third party. The note matured on September 15, 2024, and bears interest at 8% per annum. As of September 30, 2024 and December 31, 2023, there is $2,099 and $586 of interest accrued on this note, respectively.

10000

0.06

1425

972

10000

0.06

1424

970

7630

0.10

1766

1189

25000

0.08

3918

2405

15000

2023-07-06

0.085

2218

1254

12000

2023-09-13

0.085

1590

819

25000

2024-05-11

0.08

2795

1282

25000

2024-05-15

0.08

2773

1260

25000

2024-09-01

0.08

2175

663

50000

2024-09-06

0.08

4296

1271

50000

2024-09-15

0.08

2099

586

NOTE 5 – RELATED PARTY TRANSACTIONS Forty 7 Select Holdings LLC (“Forty 7”) has advanced the Company funds, to pay for general operating expenses. Forty 7 is controlled by Greg Shockey, an existing shareholder of the Company. As of September 30, 2024 and December 31, 2023, the balance due to Forty 7 is $15,000 and $15,000, respectively. On January 10, 2023, the Company issued a note payable for $15,000 to Forty 7. The note matured on July 10, 2023, and bears interest at 8.5% per annum. As of September 30, 2024 and December 31, 2023, there is $2,204 and $1,240 of interest accrued on this note, respectively. This note is currently in default. Refer to Note 7 for options to purchase shares of common stock issued to related parties. On December 22, 2023, the Company entered into the following transactions: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">1)</td> <td style="text-align: justify">An Asset Purchase Agreement (the “Asset Purchase Agreement”) with Phitech Management, LLC, a limited liability company organized under the laws of Minnesota (“Phitech”); and</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td>2)</td> <td style="text-align: justify">An Agreement and Plan of Merger (the “Merger Agreement”) with Pointward Inc., a corporation organized under the laws of Delaware (“Pointward”).</td></tr> </table> Asset Purchase Agreement Pursuant to the terms of the Asset Purchase Agreement dated December 22, 2023, the Company has agreed to pay an aggregate purchase price of $2,500,000, plus the assumption of the assumed liabilities as defined in such Asset Purchase Agreement, for Phitech’s assets, including its proprietary technology; and, upon consummation of the transaction, the Company shall cancel 10,000,000 shares of the Company’s common stock held by Phitech, representing 100% of Phitech’s ownership of the Company, and such shares shall be returned to the Company’s treasury. Agreement and Plan of Merger Following consummation of the Asset Purchase Agreement on December 22, 2023, the Company entered into a Merger Agreement with Pointward. Pursuant to the terms of the Merger Agreement, the Company shall be the surviving corporation and all the outstanding capital stock of Pointward was converted into shares of the Company’s common stock. Accordingly, the Company issued 39,252,000 shares of the Company’s common stock to the former holders of Pointward and the former stockholders of Pointward (not including any ownership of the Company’s capital stock held by such persons prior to the Merger) hold approximately 72% of the outstanding shares of the Company’s capital stock. As former stockholders of Pointward, Peter Hager, Eric Swann, Greg Shockey, and Thomas Spruce received shares of the Company’s capital stock. Peter Hager is the Company’s Chief Executive Officer. Eric Swann and Greg Shockey are consultants of the Company. Thomas Spruce is the Company’s Chief Operations Officer and director. Peter Hager, our CEO, controls both Phitech and Pointward and as a result the transaction with Pointward has been accounted for as a common control merger. As a result, the assets and liabilities assumed were recorded on the Company’s financial statements at their respective carry-over basis. Under ASC 805, “Business Combinations,” the Company recorded the common control merger as of the earliest date presented in these unaudited condensed financial statements, or December 31, 2023.

15000

2023-07-10

0.085

2204

1240

2500000 10000000

39252000

NOTE 6 – PREFERRED STOCK The Company has designated 1,000 shares of Series A Preferred Stock. The shares of Series A Preferred Stock have a par value of $0.0001 per share. The Series A Preferred Shares do not have a dividend rate or liquidation preference and are not convertible into shares of common stock. Series A Preferred Stock, voting together as a class, have the right to vote 60% of the Company’s voting shares on any and all shareholder matters (the “Majority Voting Rights”). Additionally, the Company shall not adopt any amendments to the Company’s Bylaws, Articles of Incorporation, as amended, make any changes to the Certificate of Designations establishing the Series A Preferred Stock, or effect any reclassification of the Series A Preferred Stock, without the affirmative vote of at least a majority of the outstanding shares of Series A Preferred Stock. However, the Company may, by any means authorized by law and without any vote of the holders of shares of Series A Preferred Stock, make technical, corrective, administrative or similar changes to such Certificate of Designations that do not, individually or in the aggregate, adversely affect the rights or preferences of the holders of shares of Series A Preferred Stock. Other than the Majority Voting Rights, the Series A Preferred Stock does not have any other dividend, liquidation, conversion, or redemption rights, whatsoever.

1000

0.0001

NOTE 7 – OPTIONS Greg Shockey Effective April 12, 2022, the Company entered into an Advisory Agreement with Greg Shockey, an affiliate of the Company and service provider. Under this Advisory Agreement, the Company issued options to purchase <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20220411__20220412__srt--CounterpartyNameAxis__custom--GregShockeyMember_zxJg1m3Yagti" title="Options granted">240,000 restricted shares of the Company’s common stock at a strike price of $0.39 per share. The options vested over a period of one year and expire 10 years from the date of grant. On February 1, 2023, the Company entered into an Advisor Agreement with Greg Shockey, which supersedes his previous Advisor Agreement with the Company, whereby, in exchange for business development and strategy consulting, investor relations, and facilitating meetings with targeted investors, as well as other services, the Company agreed to issue Greg Shockey options to purchase 60,000 restricted shares of common stock at signing and an additional 1,200,000 shares of restricted common stock every year thereafter. On October 12, 2023, the Company entered into a revised Stock Option Grant and Stock Option Agreement with Greg Shockey (the “Shockey Grant and Agreement”), in accordance with the terms of the Company’s 2023 Equity Incentive Plan. The Shockey Grant and Agreement supersedes his previous stock option grant and stock option agreement dated April 12, 2023. Pursuant to the terms of the Shockey Grant and Agreement, the Company agreed to issue Greg Shockey options to purchase <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_c20231011__20231012__us-gaap--TypeOfArrangementAxis__custom--ShockeyGrantAndAgreementMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z3g5fHkeEgu5" title="Options to purchase shares">3,840,000 shares of the Company’s common stock, with 1,140,000 of the shares vesting on October 12, 2023 and one-ninth (1/9th) of the remaining shares vesting on the first day of each fiscal quarter thereafter, subject to Greg Shockey continuing to be a service provider through each such date. Danijella Dragas Effective April 12, 2022, the Company entered into an Advisory Agreement with Danijella Dragas, a third-party service provider. Under this Advisory Agreement, the Company issued options to purchase <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20220411__20220412__srt--CounterpartyNameAxis__custom--DanijellaDragasMember_z40VXGwRDjO1" title="Options granted">240,000 restricted shares of the Company’s common stock at a strike price of $0.39 per share. The options vest over a period of 1 year contingent upon service and expire 10 years from the date of grant. On March 23, 2023, the Advisory Agreement was cancelled, thereby terminating Danijella Dragas and forfeiting 60,000 unvested options. Thomas Spruce In the first quarter of 2022, the Company entered into an Employment Agreement with Thomas Spruce, an officer and director of the Company. This Employment Agreement has a term of two years and automatically renews for an additional 6-month term unless terminated earlier. This agreement is terminable by each of the parties upon written notice. Under this Employment Agreement, the Company pays a base salary of $1.00 per year and issued options to purchase <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20220101__20220331__srt--CounterpartyNameAxis__custom--ThomasSpruceMember_zzP4dVcwqBvf" title="Options granted">500,000 restricted shares of the Company’s common stock at a strike price of $0.39 per share. The options vest over a period of two years and expire 10 years from the date of grant. On May 27, 2022, the Company entered into an Addendum to Employment Agreement with Thomas Spruce, which granted Mr. Spruce options to purchase an additional <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20220526__20220527__srt--CounterpartyNameAxis__custom--ThomasSpruceMember_z8ugqouoz0f" title="Options granted">250,000 restricted shares of the Company’s common stock at a strike price of $0.15 per share. The options vest immediately from the date of the grant and expire 10 years from the date of grant. On February 1, 2023, Thomas Spruce was appointed as the Company’s Secretary and Chief Operations Officer. Per the terms of the employment agreement, Mr. Spruce was granted options to purchase <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230130__20230201__srt--CounterpartyNameAxis__custom--ThomasSpruceMember__srt--TitleOfIndividualAxis__custom--ChiefOperationsOfficerMember_zn1wXZsnA6la" title="Options granted">1,750,000 restricted shares of the Company’s common stock, at the commencement of his initial term of services, for an exercise price $<span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230201__srt--TitleOfIndividualAxis__custom--ChiefOperationsOfficerMember__srt--CounterpartyNameAxis__custom--ThomasSpruceMember_z4rwMd08G5N2" title="Exercise price">0.06 per share, vesting with respect to the first <span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_c20230130__20230201__srt--TitleOfIndividualAxis__custom--ChiefOperationsOfficerMember__srt--CounterpartyNameAxis__custom--ThomasSpruceMember_zenFys4z4TYe" title="Vesting shares">250,000 shares on February 1, 2023 and vesting with respect to the remaining <span id="xdx_90B_ecustom--RemainingForVesting_c20230130__20230201__srt--TitleOfIndividualAxis__custom--ChiefOperationsOfficerMember__srt--CounterpartyNameAxis__custom--ThomasSpruceMember_z143zOGFQY3" title="Remaining for vesting">1,500,000 shares in installments of <span id="xdx_90D_ecustom--InstallmentsShares_c20230130__20230201__srt--TitleOfIndividualAxis__custom--ChiefOperationsOfficerMember__srt--CounterpartyNameAxis__custom--ThomasSpruceMember_zYJWHRKtMvH9" title="Installments shares">125,000 shares per fiscal quarter with the first vesting date of April 1, 2023 and <span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_c20230329__20230402__srt--TitleOfIndividualAxis__custom--ChiefOperationsOfficerMember__srt--CounterpartyNameAxis__custom--ThomasSpruceMember_zE1PEAIpKHEk" title="Vesting shares">250,000 options to purchase restricted shares of the Company’s common stock, at the commencement of his first renewal term of service. On October 12, 2023, the Company entered into a new Employment Agreement and Stock Option Grant and Agreement with Thomas Spruce, Chief Operations Officer and sole Director (the “Spruce Employment Agreement and Grant”), in accordance with the terms of the Company’s 2023 Equity Incentive Plan. The Spruce Employment Agreement and Grant supersedes his previous employment agreement and stock option grant and agreement, each dated February 1, 2023. Thomas Spruce’s new employment agreement provides a 36-month term of employment from October 12, 2023, under the same compensation terms as the previous Agreement, except that the number of Stock Options granted increased from 500,000 per year to 1,200,000 per year in line with Mr. Spruce’s responsibilities in moving the Company from start-up to being fully operational. Pursuant to the terms of the Spruce Employment Agreement and Grant, the Company agreed to issue Thomas Spruce options to purchase <span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeIssued_c20231011__20231012__us-gaap--TypeOfArrangementAxis__custom--SpruceEmploymentAgreementAndGrantMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zJOlc0rFrQZ1" title="Options to purchase shares">4,850,000 shares of the Company’s common stock, with 1,550,000 of the shares vesting on October 12, 2023 and one-eleventh (1/11th) of the remaining shares vesting on the first day of each fiscal quarter thereafter, subject to Thomas Spruce continuing to be a service provider through each such date. Jim Kellogg On November 16, 2022, the Company entered into an Employment Agreement with Jim Kellogg, which granted Mr. Kellogg options to purchase <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20221115__20221116__srt--CounterpartyNameAxis__custom--JimKelloggMember_zlE7rUiAlu1g" title="Options granted">300,000 restricted shares of the Company’s common stock at a strike price of $0.10 per share. The options vest over a period of 1 year contingent upon service and expire 10 years from the date of grant. On October 12, 2023, the Company entered into a new Employment Agreement and Stock Option Grant and Agreement with Jim Kellogg, Chief Financial Officer (the “Kellogg Employment Agreement and Grant”), in accordance with the terms of the Company’s 2023 Equity Incentive Plan. The Kellogg Employment Agreement and Grant supersedes his previous Employment Agreement and Stock Option Grant and Agreement dated November 16, 2022. The new Employment Agreement provides a 36-month term of employment from October 12, 2023, under the same compensation terms as the previous Agreement, except that the number of Stock Options granted increased from 300,000 per year to <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease_c20231011__20231012__us-gaap--TypeOfArrangementAxis__custom--KelloggEmploymentAgreementAndGrantMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zHqG2GPz6cZ5" title="Stock options increased granted shares">400,000 per year. Pursuant to the terms of the Kellogg Employment Agreement and Grant, the Company agreed to issue Jim Kellogg options to purchase <span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeIssued_c20231011__20231012__us-gaap--TypeOfArrangementAxis__custom--KelloggEmploymentAgreementAndGrantMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zDCBGLohLJ19" title="Options to purchase shares">1,500,000 shares of the Company’s common stock, with 300,000 of the shares vesting on October 12, 2023 and one-twelfth (1/12th) of the remaining shares vesting on the first day of each fiscal quarter beginning on January 1, 2024, subject to Jim Kellogg continuing to be a service provider through each such date. Peter Hager On February 1, 2023, Peter Hager was appointed as the Company’s President and Chief Executive Officer. Per the terms of the employment agreement, Mr. Hager was granted options to purchase <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230131__20230201__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zATfGinH4vN5" title="Options grants to purchase">6,400,000 restricted shares of the Company’s common stock, at the commencement of his initial term of services, for an exercise price $0.06 per share, vesting in installments of 500,000 shares per fiscal quarter with the first vesting date of April 1, 2023 and <span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_c20230130__20230201__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zqJmkPBbMYB6" title="Vesting shares">1,000,000 options to purchase restricted shares of the Company’s common stock, at the commencement of his first renewal term of service. On October 12, 2023, the Company entered into a revised Stock Option Grant and Agreement with Peter Hager, President and Chief Executive Officer (the “Hager Grant and Agreement”), in accordance with the terms of the Company’s 2023 Equity Incentive Plan. The Hager Grant and Agreement supersedes his previous Stock Option Grant and Agreement dated February 1, 2023. Pursuant to the terms of the Hager Grant and Agreement, the Company agreed to issue Peter Hager options to purchase <span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeIssued_c20231011__20231012__us-gaap--TypeOfArrangementAxis__custom--HagerGrantAndAgreementMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zLa2J6tWY7bb" title="Options to purchase shares">6,400,000 shares of the Company’s common stock, with 1,900,000 of the shares vesting on October 12, 2023 and one-ninth (1/9th) of the remaining shares vesting on the first day of each fiscal quarter thereafter, subject to Peter Hager continuing to be a service provider through each such date. The February 1, 2023 Options were issued with the following inputs: <table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfAssumptionsForFairValueAsOfBalanceSheetDateOfInterestsContinuedToBeHeldByTransferorServicingAssetsOrServicingLiabilitiesTextBlock_hus-gaap--AwardDateAxis__custom--OptionsIssuedFeb2023Member_zbltAf946iHi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPTIONS (Details - Schedule of assumptions for fair value February 2023)"> <tr style="vertical-align: bottom"> <td>Schedule of assumptions for fair value</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%">Options</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230201__us-gaap--AwardTypeAxis__custom--OptionsIssuedFeb2023Member_zmRP9HHMeFE1" style="width: 13%; text-align: right" title="Options">11,810,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Share price</td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--SharePrice_iI_c20230201__us-gaap--AwardTypeAxis__custom--OptionsIssuedFeb2023Member_zadmnj9WDryj" style="text-align: right" title="Share price">0.066</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Exercise Price</td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20230201__us-gaap--AwardTypeAxis__custom--OptionsIssuedFeb2023Member_z0XvixDNt562" style="text-align: right" title="Exercise Price">0.06</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Term</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230130__20230201__us-gaap--AwardTypeAxis__custom--OptionsIssuedFeb2023Member_zeQWiLbPXGs9" title="Term">10 years</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20230130__20230201__us-gaap--AwardTypeAxis__custom--OptionsIssuedFeb2023Member_z8bzM1sztwme" title="Volatility">209.39%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk Free Interest Rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20230130__20230201__us-gaap--AwardTypeAxis__custom--OptionsIssuedFeb2023Member_zTpYonMeYFs2" title="Risk Free Interest Rate">3.39%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Dividend rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp0_c20230130__20230201__us-gaap--AwardTypeAxis__custom--OptionsIssuedFeb2023Member_zywtIV0K2MUd" style="text-align: right" title="Dividend rate">–</td><td style="text-align: left"> </td></tr> </table> Effective September 28, 2023, the Company entered into an Advisory Agreement with Jonathan Sweetser, a third-party service provider. Under this Advisory Agreement, the Company issued options to purchase <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230927__20230928__srt--CounterpartyNameAxis__custom--JonathanSweetserMember_zMXCg1zTcPW9" title="Options granted">60,000 restricted shares of the Company’s common stock upon signing and 1,200,000 shares per year over the next three years. The options were issued at a strike price of $0.07 per share. The options vest over a period of 1 year contingent upon service and expire 10 years from the date of grant. Effective September 28, 2023, the Company entered into an Advisory Agreement with Heather Rawls, a third-party service provider. Under this Advisory Agreement, the Company issued options to purchase <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230927__20230928__srt--CounterpartyNameAxis__custom--HeatherRawlsMember_zE1FeOxbRc7d" title="Options granted">100,000 restricted shares of the Company’s common stock at a strike price of $0.07 per share. The options vest over a period of 1 year contingent upon service and expire 10 years from the date of grant. Options were issued with the following inputs: <table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfAssumptionsForOptionsIssuedTableTextBlock_hus-gaap--AwardDateAxis__custom--OptionsIssuedSept2023Member_zV4iBndepDBe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPTIONS (Details - Schedule of assumptions for fair value September 2023)"> <tr style="vertical-align: bottom"> <td>Schedule of assumptions for fair value</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%">Options</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230928__us-gaap--AwardDateAxis__custom--OptionsIssuedSept2023Member_z8nFScfsz1h8" style="width: 13%; text-align: right" title="Options">3,760,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Share price</td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--SharePrice_iI_c20230928__us-gaap--AwardDateAxis__custom--OptionsIssuedSept2023Member_zfOs9L6MNme7" style="text-align: right" title="Share price">0.07</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Exercise Price</td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20230928__us-gaap--AwardDateAxis__custom--OptionsIssuedSept2023Member_zqQavdtysftj" style="text-align: right" title="Exercise Price">0.07</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Term</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230927__20230928__us-gaap--AwardDateAxis__custom--OptionsIssuedSept2023Member_ztLEhwUPHDBc" title="Term">10 years</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPure_c20230927__20230928__us-gaap--AwardDateAxis__custom--OptionsIssuedSept2023Member_zEyVmOzVWNo3" title="Volatility">172.47%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk Free Interest Rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPure_c20230927__20230928__us-gaap--AwardDateAxis__custom--OptionsIssuedSept2023Member_zQesus7IybVj" title="Risk Free Interest Rate">4.59%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Dividend rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp0_c20230927__20230928__us-gaap--AwardDateAxis__custom--OptionsIssuedSept2023Member_zXToh0Zp3ze9" style="text-align: right" title="Dividend rate">–</td><td style="text-align: left"> </td></tr> </table> During the quarter ended September 30, 2023, the Company accounted for 300,000 options that were effective on November 16, 2022. The option has a strike price of $0.10 per share. The options vest over a period of 1 year contingent upon service and expire 10 years from the date of grant. Options were issued with the following inputs: <table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--AwardDateAxis__custom--OptionsIssuedNov2022Member_zWlQch2BnDCd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPTIONS (Details - Schedule of assumptions for fair value November 2022)"> <tr style="vertical-align: bottom"> <td>Schedule of assumptions for fair value</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%">Options</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230930__us-gaap--AwardDateAxis__custom--OptionsIssuedNov2022Member_zl36RucdokAi" style="width: 13%; text-align: right" title="Options">300,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Share price</td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--SharePrice_iI_c20230930__us-gaap--AwardDateAxis__custom--OptionsIssuedNov2022Member_zihrPKR3R9C1" style="text-align: right" title="Share price">0.10</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Exercise Price</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__us-gaap--AwardDateAxis__custom--OptionsIssuedNov2022Member_ziDGujFwM0cf" style="text-align: right" title="Exercise Price">0.10</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Term</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230701__20230930__us-gaap--AwardDateAxis__custom--OptionsIssuedNov2022Member_z60gET1ePAk4" title="Term">10 years</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20230701__20230930__us-gaap--AwardDateAxis__custom--OptionsIssuedNov2022Member_z0jwet3hz7Qh" title="Volatility">190.439%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk Free Interest Rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20230701__20230930__us-gaap--AwardDateAxis__custom--OptionsIssuedNov2022Member_zA2PEapFSAfh" title="Risk Free Interest Rate">3.67%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Dividend rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp0_c20230701__20230930__us-gaap--AwardDateAxis__custom--OptionsIssuedNov2022Member_zz0arkjBYIZ7" style="text-align: right" title="Dividend rate">–</td><td style="text-align: left"> </td></tr> </table> A summary of the status of the Company’s outstanding stock options and changes during the year is presented below: <table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zFqng9HVc5Aa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPTIONS (Details - Schedule of options activity)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Schedule of options activity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Number of Options</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Remaining Contract Term</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Aggregate Intrinsic Value</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 36%">Outstanding at December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zhPGcGVVYXMd" style="width: 12%; text-align: right" title="Options outstanding, beginning balance">1,780,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zRSZcY7USpkc" style="width: 12%; text-align: right" title="Weighted average exercise price, beginning balance">0.35</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zGhe86Amoaji" title="Weighted average remaining contract term">9.81</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">–</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zSLqqiodO9Z5" style="text-align: right" title="Number of options, granted">20,350,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_z06Gy0Zp7WWc" style="text-align: right" title="Weighted average exercise price, granted">0.07</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_ecustom--OptionsOutstandingGrantedTerm_dtY_c20230101__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zn4eYJqY2cYi" title="Weighted average remaining contract term, granted">9.78</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt">Cancelled</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20230101__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_ztiKAFNtlR9j" style="text-align: right" title="Number of options, cancelled">(800,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1pt">Exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_d0_c20230101__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zTJvqYWrpTWl" style="border-bottom: Black 1pt solid; text-align: right" title="Options exercised">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Outstanding at December 31, 2023</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20240101__20240930__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zR7DocG68q75" style="text-align: right" title="Options outstanding, beginning balance">21,330,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20240101__20240930__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_z0rIr18iaWof" style="text-align: right" title="Weighted average exercise price, beginning balance">0.08</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zTtU0huvSJG1" title="Weighted average remaining contract term">9.74</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_d0_c20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zR2EWK96MUl2" title="Aggregate intrinsic value">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d0_c20240101__20240930__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zO8vwO3RgMud" style="text-align: right" title="Options granted">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d0_c20240101__20240930__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zIzDbU7TXEmf" style="text-align: right" title="Weighted average exercise price, granted">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt">Cancelled</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di0_c20240101__20240930__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zvrQmO9dBsKh" style="text-align: right" title="Options cancelled">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; padding-left: 10pt">Exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left"> </td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_d0_c20240101__20240930__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zikV6NGEijHk" style="border-bottom: Black 1pt solid; text-align: right" title="Options exercised">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Outstanding at September 30, 2024</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20240101__20240930__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zpgFjZ59YoB5" style="border-bottom: Black 2.5pt double; text-align: right" title="Options outstanding, ending balance">21,330,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20240101__20240930__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_z8DEeErxv2sj" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, ending balance">0.08</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_d0_c20240930__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zuFdgb2MGP0e" title="Aggregate intrinsic value">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Exercisable at September 30, 2024</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20240930__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zJAcpfTJ8wYe" style="border-bottom: Black 2.5pt double; text-align: right" title="Options exercisable">10,805,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20240930__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zZLvj0EuSgre" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, exercisable">0.08</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240101__20240930__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zo0CIzLEDvu5" title="Weighted average remaining contract term, exercisable">8.36</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_d0_c20240930__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zvc5HvxIdbCl" title="Aggregate intrinsic value, exercisable">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_z6N4TE9msxid" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - OPTIONS (Details - Schedule of stock options activity number of shares)"> <tr style="vertical-align: bottom"> <td style="text-align: center">Schedule of stock options activity number of shares</td> <td style="white-space: nowrap"> </td> <td style="text-align: center"> </td> <td style="white-space: nowrap"> </td> <td style="text-align: center"> </td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid; width: 23%; text-align: center">Range of Exercise Prices</td> <td style="white-space: nowrap; width: 2%"> </td> <td style="border-bottom: black 1pt solid; width: 23%; text-align: center">Number Outstanding 9/30/2024</td> <td style="white-space: nowrap; width: 2%"> </td> <td style="border-bottom: black 1pt solid; width: 23%; text-align: center">Weighted Average Remaining Contractual Life</td> <td style="white-space: nowrap; width: 2%"> </td> <td style="border-bottom: black 1pt solid; white-space: nowrap; width: 23%; text-align: center">Weighted Average Exercise Price</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center">$0.06 – $0.39</td> <td style="white-space: nowrap"> </td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20240930_zXGuhcca6it" style="text-align: center" title="Number of share outstanding">21,330,000</td> <td style="white-space: nowrap"> </td> <td style="text-align: center"><span id="xdx_90D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20240101__20240930_zuJeSU8MaVYa" title="Weighted average remaining contractual life">8.36 years</td> <td style="white-space: nowrap"> </td> <td id="xdx_985_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20240930_zDRAx3txXX33" style="text-align: center" title="Weighted average exercise price">$0.08</td></tr> </table>

240000

60000 1200000

3840000

240000

500000

250000

1750000

0.06

250000

1500000 125000

250000

4850000

300000

400000

1500000

6400000

0.06

500000

1000000

6400000

<table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfAssumptionsForFairValueAsOfBalanceSheetDateOfInterestsContinuedToBeHeldByTransferorServicingAssetsOrServicingLiabilitiesTextBlock_hus-gaap--AwardDateAxis__custom--OptionsIssuedFeb2023Member_zbltAf946iHi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPTIONS (Details - Schedule of assumptions for fair value February 2023)"> <tr style="vertical-align: bottom"> <td>Schedule of assumptions for fair value</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%">Options</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230201__us-gaap--AwardTypeAxis__custom--OptionsIssuedFeb2023Member_zmRP9HHMeFE1" style="width: 13%; text-align: right" title="Options">11,810,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Share price</td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--SharePrice_iI_c20230201__us-gaap--AwardTypeAxis__custom--OptionsIssuedFeb2023Member_zadmnj9WDryj" style="text-align: right" title="Share price">0.066</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Exercise Price</td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20230201__us-gaap--AwardTypeAxis__custom--OptionsIssuedFeb2023Member_z0XvixDNt562" style="text-align: right" title="Exercise Price">0.06</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Term</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230130__20230201__us-gaap--AwardTypeAxis__custom--OptionsIssuedFeb2023Member_zeQWiLbPXGs9" title="Term">10 years</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20230130__20230201__us-gaap--AwardTypeAxis__custom--OptionsIssuedFeb2023Member_z8bzM1sztwme" title="Volatility">209.39%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk Free Interest Rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20230130__20230201__us-gaap--AwardTypeAxis__custom--OptionsIssuedFeb2023Member_zTpYonMeYFs2" title="Risk Free Interest Rate">3.39%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Dividend rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp0_c20230130__20230201__us-gaap--AwardTypeAxis__custom--OptionsIssuedFeb2023Member_zywtIV0K2MUd" style="text-align: right" title="Dividend rate">–</td><td style="text-align: left"> </td></tr> </table>

11810000

0.066

0.06

P10Y

2.0939

0.0339

60000

100000

<table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfAssumptionsForOptionsIssuedTableTextBlock_hus-gaap--AwardDateAxis__custom--OptionsIssuedSept2023Member_zV4iBndepDBe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPTIONS (Details - Schedule of assumptions for fair value September 2023)"> <tr style="vertical-align: bottom"> <td>Schedule of assumptions for fair value</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%">Options</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230928__us-gaap--AwardDateAxis__custom--OptionsIssuedSept2023Member_z8nFScfsz1h8" style="width: 13%; text-align: right" title="Options">3,760,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Share price</td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--SharePrice_iI_c20230928__us-gaap--AwardDateAxis__custom--OptionsIssuedSept2023Member_zfOs9L6MNme7" style="text-align: right" title="Share price">0.07</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Exercise Price</td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20230928__us-gaap--AwardDateAxis__custom--OptionsIssuedSept2023Member_zqQavdtysftj" style="text-align: right" title="Exercise Price">0.07</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Term</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230927__20230928__us-gaap--AwardDateAxis__custom--OptionsIssuedSept2023Member_ztLEhwUPHDBc" title="Term">10 years</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPure_c20230927__20230928__us-gaap--AwardDateAxis__custom--OptionsIssuedSept2023Member_zEyVmOzVWNo3" title="Volatility">172.47%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk Free Interest Rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPure_c20230927__20230928__us-gaap--AwardDateAxis__custom--OptionsIssuedSept2023Member_zQesus7IybVj" title="Risk Free Interest Rate">4.59%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Dividend rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp0_c20230927__20230928__us-gaap--AwardDateAxis__custom--OptionsIssuedSept2023Member_zXToh0Zp3ze9" style="text-align: right" title="Dividend rate">–</td><td style="text-align: left"> </td></tr> </table>

3760000

0.07

P10Y

1.7247

0.0459

<table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--AwardDateAxis__custom--OptionsIssuedNov2022Member_zWlQch2BnDCd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPTIONS (Details - Schedule of assumptions for fair value November 2022)"> <tr style="vertical-align: bottom"> <td>Schedule of assumptions for fair value</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%">Options</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230930__us-gaap--AwardDateAxis__custom--OptionsIssuedNov2022Member_zl36RucdokAi" style="width: 13%; text-align: right" title="Options">300,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Share price</td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--SharePrice_iI_c20230930__us-gaap--AwardDateAxis__custom--OptionsIssuedNov2022Member_zihrPKR3R9C1" style="text-align: right" title="Share price">0.10</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Exercise Price</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__us-gaap--AwardDateAxis__custom--OptionsIssuedNov2022Member_ziDGujFwM0cf" style="text-align: right" title="Exercise Price">0.10</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Term</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230701__20230930__us-gaap--AwardDateAxis__custom--OptionsIssuedNov2022Member_z60gET1ePAk4" title="Term">10 years</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20230701__20230930__us-gaap--AwardDateAxis__custom--OptionsIssuedNov2022Member_z0jwet3hz7Qh" title="Volatility">190.439%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk Free Interest Rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20230701__20230930__us-gaap--AwardDateAxis__custom--OptionsIssuedNov2022Member_zA2PEapFSAfh" title="Risk Free Interest Rate">3.67%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Dividend rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp0_c20230701__20230930__us-gaap--AwardDateAxis__custom--OptionsIssuedNov2022Member_zz0arkjBYIZ7" style="text-align: right" title="Dividend rate">–</td><td style="text-align: left"> </td></tr> </table>

300000

0.10

P10Y

1.90439

0.0367

<table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zFqng9HVc5Aa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPTIONS (Details - Schedule of options activity)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Schedule of options activity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Number of Options</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Remaining Contract Term</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Aggregate Intrinsic Value</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 36%">Outstanding at December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zhPGcGVVYXMd" style="width: 12%; text-align: right" title="Options outstanding, beginning balance">1,780,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zRSZcY7USpkc" style="width: 12%; text-align: right" title="Weighted average exercise price, beginning balance">0.35</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zGhe86Amoaji" title="Weighted average remaining contract term">9.81</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">–</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zSLqqiodO9Z5" style="text-align: right" title="Number of options, granted">20,350,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_z06Gy0Zp7WWc" style="text-align: right" title="Weighted average exercise price, granted">0.07</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_ecustom--OptionsOutstandingGrantedTerm_dtY_c20230101__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zn4eYJqY2cYi" title="Weighted average remaining contract term, granted">9.78</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt">Cancelled</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20230101__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_ztiKAFNtlR9j" style="text-align: right" title="Number of options, cancelled">(800,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1pt">Exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_d0_c20230101__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zTJvqYWrpTWl" style="border-bottom: Black 1pt solid; text-align: right" title="Options exercised">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Outstanding at December 31, 2023</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20240101__20240930__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zR7DocG68q75" style="text-align: right" title="Options outstanding, beginning balance">21,330,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20240101__20240930__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_z0rIr18iaWof" style="text-align: right" title="Weighted average exercise price, beginning balance">0.08</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zTtU0huvSJG1" title="Weighted average remaining contract term">9.74</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_d0_c20231231__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zR2EWK96MUl2" title="Aggregate intrinsic value">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d0_c20240101__20240930__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zO8vwO3RgMud" style="text-align: right" title="Options granted">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d0_c20240101__20240930__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zIzDbU7TXEmf" style="text-align: right" title="Weighted average exercise price, granted">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt">Cancelled</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di0_c20240101__20240930__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zvrQmO9dBsKh" style="text-align: right" title="Options cancelled">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; padding-left: 10pt">Exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left"> </td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_d0_c20240101__20240930__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zikV6NGEijHk" style="border-bottom: Black 1pt solid; text-align: right" title="Options exercised">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Outstanding at September 30, 2024</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20240101__20240930__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zpgFjZ59YoB5" style="border-bottom: Black 2.5pt double; text-align: right" title="Options outstanding, ending balance">21,330,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20240101__20240930__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_z8DEeErxv2sj" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, ending balance">0.08</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_d0_c20240930__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zuFdgb2MGP0e" title="Aggregate intrinsic value">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Exercisable at September 30, 2024</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20240930__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zJAcpfTJ8wYe" style="border-bottom: Black 2.5pt double; text-align: right" title="Options exercisable">10,805,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20240930__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zZLvj0EuSgre" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, exercisable">0.08</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240101__20240930__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zo0CIzLEDvu5" title="Weighted average remaining contract term, exercisable">8.36</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_d0_c20240930__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zvc5HvxIdbCl" title="Aggregate intrinsic value, exercisable">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

1780000

0.35

P9Y9M21D

20350000

0.07

P9Y9M10D

800000

21330000

0.08

P9Y8M26D

-0

21330000

0.08

10805000

0.08

P8Y4M9D

<table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_z6N4TE9msxid" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - OPTIONS (Details - Schedule of stock options activity number of shares)"> <tr style="vertical-align: bottom"> <td style="text-align: center">Schedule of stock options activity number of shares</td> <td style="white-space: nowrap"> </td> <td style="text-align: center"> </td> <td style="white-space: nowrap"> </td> <td style="text-align: center"> </td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid; width: 23%; text-align: center">Range of Exercise Prices</td> <td style="white-space: nowrap; width: 2%"> </td> <td style="border-bottom: black 1pt solid; width: 23%; text-align: center">Number Outstanding 9/30/2024</td> <td style="white-space: nowrap; width: 2%"> </td> <td style="border-bottom: black 1pt solid; width: 23%; text-align: center">Weighted Average Remaining Contractual Life</td> <td style="white-space: nowrap; width: 2%"> </td> <td style="border-bottom: black 1pt solid; white-space: nowrap; width: 23%; text-align: center">Weighted Average Exercise Price</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center">$0.06 – $0.39</td> <td style="white-space: nowrap"> </td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20240930_zXGuhcca6it" style="text-align: center" title="Number of share outstanding">21,330,000</td> <td style="white-space: nowrap"> </td> <td style="text-align: center"><span id="xdx_90D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20240101__20240930_zuJeSU8MaVYa" title="Weighted average remaining contractual life">8.36 years</td> <td style="white-space: nowrap"> </td> <td id="xdx_985_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20240930_zDRAx3txXX33" style="text-align: center" title="Weighted average exercise price">$0.08</td></tr> </table>

0.06

0.39

21330000

P8Y4M9D

0.08

NOTE 8 – WARRANTS A summary of the status of the Company’s outstanding stock warrants and changes during the year is presented below: <table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_zXUBuT8JsW7k" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - WARRANTS (Details - Schedule of outstanding stock warrants and changes)"> <tr style="vertical-align: bottom"> <td>Schedule of outstanding stock warrants and changes</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Number of Warrants</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Remaining Contract Term</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Aggregate Intrinsic Value</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 36%">Outstanding at December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20230101__20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--StockWarrantsMember_z5fOQ19nH4L7" style="width: 12%; text-align: right" title="Number of warrants outstanding, beginning">153,503</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20230101__20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--StockWarrantsMember_zvFmEPQp6hlj" style="width: 12%; text-align: right" title="Weighted average exercise price, beginning">0.25</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingTerm_iS_dtY_c20230101__20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--StockWarrantsMember_zgUvKToGB6Cf" title="Weighted average remaining contract term, beginning">5.92</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">–</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d0_c20230101__20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--StockWarrantsMember_zKhfeJfWiida" style="text-align: right" title="Number of warrants outstanding, granted">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d0_c20230101__20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--StockWarrantsMember_zxzxUKrEPlSc" style="text-align: right" title="Weighted average exercise price, granted">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt">Expired</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1pt">Exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Exercisable at December 31, 2023</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20240101__20240930__us-gaap--ClassOfWarrantOrRightAxis__custom--StockWarrantsMember_z7LQ9h7K2ilc" style="text-align: right" title="Number of warrants outstanding, beginning">153,503</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20240101__20240930__us-gaap--ClassOfWarrantOrRightAxis__custom--StockWarrantsMember_zudiwKUknhf8" style="text-align: right" title="Weighted average exercise price, beginning">0.25</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingTerm_iS_dtY_c20240101__20240930__us-gaap--ClassOfWarrantOrRightAxis__custom--StockWarrantsMember_zGhbxkqtCXqg" title="Weighted average remaining contract term, beginning">5.67</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iI_d0_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--StockWarrantsMember_zaKrt8wZBuSf" title="Aggregate intrinsic value">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d0_c20240101__20240930__us-gaap--ClassOfWarrantOrRightAxis__custom--StockWarrantsMember_zgi1OszG04v1" style="text-align: right" title="Number of warrants outstanding, granted">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d0_c20240101__20240930__us-gaap--ClassOfWarrantOrRightAxis__custom--StockWarrantsMember_zRQr4PZI8X3i" style="text-align: right" title="Weighted average exercise price, granted">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt">Expired</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1pt">Exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Exercisable at September 30, 2024</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_c20240101__20240930__us-gaap--ClassOfWarrantOrRightAxis__custom--StockWarrantsMember_zg3BYhhgJvx7" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of warrants outstanding, ending">153,503</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20240101__20240930__us-gaap--ClassOfWarrantOrRightAxis__custom--StockWarrantsMember_zpd4Dd2RB7s9" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, ending">0.25</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingTerm_iE_dtY_c20240101__20240930__us-gaap--ClassOfWarrantOrRightAxis__custom--StockWarrantsMember_zpXaIl6Dspxf" title="Weighted average remaining contract term, ending">3.92</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iI_d0_c20240930__us-gaap--ClassOfWarrantOrRightAxis__custom--StockWarrantsMember_zdwXzDQdK5Gg" title="Aggregate intrinsic value">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

<table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_zXUBuT8JsW7k" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - WARRANTS (Details - Schedule of outstanding stock warrants and changes)"> <tr style="vertical-align: bottom"> <td>Schedule of outstanding stock warrants and changes</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Number of Warrants</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Remaining Contract Term</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Aggregate Intrinsic Value</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 36%">Outstanding at December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20230101__20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--StockWarrantsMember_z5fOQ19nH4L7" style="width: 12%; text-align: right" title="Number of warrants outstanding, beginning">153,503</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20230101__20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--StockWarrantsMember_zvFmEPQp6hlj" style="width: 12%; text-align: right" title="Weighted average exercise price, beginning">0.25</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingTerm_iS_dtY_c20230101__20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--StockWarrantsMember_zgUvKToGB6Cf" title="Weighted average remaining contract term, beginning">5.92</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">–</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d0_c20230101__20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--StockWarrantsMember_zKhfeJfWiida" style="text-align: right" title="Number of warrants outstanding, granted">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d0_c20230101__20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--StockWarrantsMember_zxzxUKrEPlSc" style="text-align: right" title="Weighted average exercise price, granted">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt">Expired</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1pt">Exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Exercisable at December 31, 2023</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20240101__20240930__us-gaap--ClassOfWarrantOrRightAxis__custom--StockWarrantsMember_z7LQ9h7K2ilc" style="text-align: right" title="Number of warrants outstanding, beginning">153,503</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20240101__20240930__us-gaap--ClassOfWarrantOrRightAxis__custom--StockWarrantsMember_zudiwKUknhf8" style="text-align: right" title="Weighted average exercise price, beginning">0.25</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingTerm_iS_dtY_c20240101__20240930__us-gaap--ClassOfWarrantOrRightAxis__custom--StockWarrantsMember_zGhbxkqtCXqg" title="Weighted average remaining contract term, beginning">5.67</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iI_d0_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--StockWarrantsMember_zaKrt8wZBuSf" title="Aggregate intrinsic value">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d0_c20240101__20240930__us-gaap--ClassOfWarrantOrRightAxis__custom--StockWarrantsMember_zgi1OszG04v1" style="text-align: right" title="Number of warrants outstanding, granted">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d0_c20240101__20240930__us-gaap--ClassOfWarrantOrRightAxis__custom--StockWarrantsMember_zRQr4PZI8X3i" style="text-align: right" title="Weighted average exercise price, granted">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt">Expired</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1pt">Exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Exercisable at September 30, 2024</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_c20240101__20240930__us-gaap--ClassOfWarrantOrRightAxis__custom--StockWarrantsMember_zg3BYhhgJvx7" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of warrants outstanding, ending">153,503</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20240101__20240930__us-gaap--ClassOfWarrantOrRightAxis__custom--StockWarrantsMember_zpd4Dd2RB7s9" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, ending">0.25</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingTerm_iE_dtY_c20240101__20240930__us-gaap--ClassOfWarrantOrRightAxis__custom--StockWarrantsMember_zpXaIl6Dspxf" title="Weighted average remaining contract term, ending">3.92</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iI_d0_c20240930__us-gaap--ClassOfWarrantOrRightAxis__custom--StockWarrantsMember_zdwXzDQdK5Gg" title="Aggregate intrinsic value">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

153503

0.25

P5Y11M1D

153503

0.25

P5Y8M1D

153503

0.25

P3Y11M1D

NOTE 9 – SUBSEQUENT EVENTS In accordance with SFAS 165 (ASC 855-10) management has performed an evaluation of subsequent events through the date that the unaudited condensed financial statements were issued and has determined that there are no material subsequent events to disclose in these unaudited condensed financial statements.

false false false false